已收盘 02-06 16:00:00 美东时间
-0.020
-0.14%
OP Bancorp press release (OPBK): Q4 GAAP EPS of $0.47. Revenue of $24.28M (+13.7% Y/Y). More on OP Bancorp Seeking Alpha’s Quant Rating on OP Bancorp Historical earnings data for OP Banco...
01-23 18:13
OP Bancorp (OPBK) declares $0.12/share quarterly dividend, in line with previous. Forward yield 3.24% Payable Feb. 19; for shareholders of record Feb. 5; ex-div Feb. 5. See OPBK Dividend Scorecard, Y...
01-23 05:47
OP Bancorp Q4 net income rises Overview California bank's Q4 net income rose 5% sequentially, driven by higher net interest income Provision for credit losses decreased 61%, reflecting a more favorable economic outlook Company's noninterest income fell 17% due to lower gains on loan sales and servic
01-23 05:40
OP Bancorp Q4 net income rises 42% to USD 7.1 million OP Bancorp reported net income of USD 7.1 million for the fourth quarter (Q4) 2025, with diluted earnings per share (EPS) of USD 0.47. Net interest income for Q4 2025 was USD 20.9 million, up 3%. Revenue reached USD 24.3 million. The provision fo
01-23 05:32
BRIEF-OP Bancorp Q4 Net Interest Income USD 20.863 Million Jan 22 (Reuters) - OP Bancorp Q4 net income USD 7.059 million. Q4 CET1 capital ratio 10.93% Q4 net interest margin 3.25% Q4 EPS USD 0.47
01-23 05:30
OP Bancorp Declares Quarterly Cash Dividend of $0.12 Per Share OP Bancorp has announced that its Board of Directors declared a quarterly cash dividend of $0.12 per share of common stock, payable on or about February 19, 2026, to shareholders of record as of February 5, 2026. Disclaimer: This news br
01-23 05:30
OP Bancorp ( ($OPBK) ) has provided an announcement. On November 7, 2025, OP Ba...
2025-11-11 06:22
今日重点评级关注:HC Wainwright & Co.:维持PepGen"买入"评级,目标价从12美元升至18美元;Piper Sandler:维持Prothena Corp"超配"评级,目标价从15美元升至36美元
2025-10-29 09:25
今日重点评级关注:Guggenheim:上调Neumora Therapeutics评级至"买入",目标价14美元;韦德布什:上调Fate Therapeutics评级至"跑赢大市",目标价从5美元升至7美元
2025-10-28 10:08
Keefe, Bruyette & Woods analyst Kelly Motta maintains OP Bancorp (NASDAQ:OPBK) with a Market Perform and raises the price target from $15.5 to $16.
2025-10-28 00:08